<--- Back to Details
First PageDocument Content
Clinical research / Pharmacology / Drug safety / United States administrative law / Food and Drug Administration / United States Office of Research Integrity / Drug Price Competition and Patent Term Restoration Act / Institutional review board / Medical device / Medicine / Science / Health
Date: 2012-08-28 04:06:57
Clinical research
Pharmacology
Drug safety
United States administrative law
Food and Drug Administration
United States Office of Research Integrity
Drug Price Competition and Patent Term Restoration Act
Institutional review board
Medical device
Medicine
Science
Health

Add to Reading List

Source URL: www.gpo.gov

Download Document from Source Website

File Size: 213,70 KB

Share Document on Facebook

Similar Documents

The EVMS Autism Spectrum Disorder Program was started by Maria Urbano, M.D., and Kathrin Hartmann, Ph.D., in 2010 to provide clinical services, research, and community outreach to individuals and their families for Autis

DocID: 1vrwY - View Document

Towards a Composite Clinical Endpoint: Identifying a Core Set of Patient and Caregiver Relevant Outcome Measures Through Qualitative Research on the Global Impact of Dravet Syndrome Rima Nabbout1, Stephane Auvin2, Cather

DocID: 1vpIt - View Document

Clinical Research Registration at Public Registry

DocID: 1vnxr - View Document

Grattoni Alessandro, Ph.D. Chairman, The Department of Nanomedicine, The Houston Methodist Research Institute, Houston, Texas (USA) Dr. Grattoni’s research is dedicated to the development and clinical translation of im

DocID: 1vi9N - View Document

Clinical & Translational Research 101 Thursday, August 10, 2017 Time Location

DocID: 1vglz - View Document